ESG Inc.

11/13/2024 | Press release | Distributed by Public on 11/13/2024 14:38

Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 10-Q

Quarterly Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the quarterly period ended September 30, 2024

Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from __________ to __________

Registration No. 000-56532

ESG INC.

(Exact name of registrant as specified in its charter)

Nevada 87-1918342
(State or Other Jurisdiction of
Incorporation or Organization)
(I.R.S. Employer
Identification No.)

523 School House Rd.

Kennett Square, PA

19348
(Address of Principal Executive Offices) (Zip Code)

267-467-5871

(Registrant's telephone number, including area code)

n/a n/a

(Former Name, former address and former fiscal year, if changed since last report)

Securities registered under Section 12(b) of the Exchange Act: None

Securities registered under Section 12(g) of the Exchange Act: None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "non-accelerated filer," " smaller reporting company," and " emerging growth company " in Rule 12b-2 of the Exchange Act. (Check all that apply):

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

State the number of shares outstanding of each of the issuer's classes of common equity, as of the latest practicable date: 25,899,468common shares issued and outstanding as of September 30, 2024.

ESG INC.

QUARTERLY REPORT ON FORM 10-Q

TABLE OF CONTENTS

Page
PART I FINANCIAL INFORMATION:
Item 1. Financial Statements (Unaudited) 1
Consolidated Balance Sheets as of September 30, 2024 (Unaudited) and December 31, 2023 1
Consolidated Statements of Operations and Comprehensive Income (Loss) for the Three and Nine Months Ended September 30, 2024 and 2023 (Unaudited) 2
Consolidated Statements of Changes in Stockholders' Equity for the Three and Nine Months Ended September 30, 2024 and 2023 (Unaudited) 3
Consolidated Statements of Cash Flows for the Nine Months ended September 30, 2024 and 2023 (Unaudited) 4
Notes to the Unaudited Financial Statements 5
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 15
Item 3. Quantitative and Qualitative Disclosures About Market Risk 16
Item 4. Controls and Procedures 16
PART II OTHER INFORMATION:
Item 1. Legal Proceedings 17
Item 1A Risk Factors 17
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 17
Item 3. Defaults Upon Senior Securities 17
Item 4. Submission of Matters to a Vote of Securities Holders 17
Item 5. Other Information 17
Item 6. Exhibits 17
Signatures 18

-i-

Part I. Financial Information

Item 1. Financial Statements (unaudited)

ESG INC.

CONSOLIDATED BALANCE SHEETS

September 30, 2024
(Unaudited)
December 31, 2023
ASSETS
Current Assets
Cash 444,835 342,342
Accounts receivable and other receivables 210,526 79,221
Advance to suppliers 1,208,222 166,010
Inventories 1,869,777 1,651,376
Total Current Assets 3,733,360 2,238,949
Property, plant and equipment, net 17,948,708 18,694,969
Intangible assets, net 3,068,514 3,085,906
Value added tax receivable 2,380,839 2,211,980
Note receivable - 41,848
Total Non-current Assets 23,398,061 24,034,703
Total Assets 27,131,421 26,273,652
LIABILITIES AND EQUITY
Current Liabilities
Short-term bank loans 6,939,101 6,904,228
Account payable 2,731,467 1,450,405
Payable to related party - 30,000
Accrued expenses and other liabilities 2,749,583 2,312,772
Deferred income 1,271,088 1,355,552
Total Current Liabilities 13,691,239 12,052,957
Long-term payable 1,334,825 1,423,116
Total Liabilities 15,026,064 13,476,073
Commitments and Contingencies
Shareholders' Equity (Deficit)
Common stock, $0.001par value, 65,000,000authorized, 25,899,468issued and outstanding as of September 30, 2024 and December 31, 2023, respectively. 25,900 25,900
Additional paid in capital 11,152,388 11,152,388
Accumulated comprehensive income (loss) (435,822 ) (430,206 )
Accumulated deficit (1,708,434 ) (1,224,811 )
Equity Attributable to stockholders of ESG Inc. 9,034,032 9,523,271
Equity attributable to noncontrolling interest 3,071,325 3,274,308
Total Equity 12,105,357 12,797,579
Total Liabilities and Stockholders' Equity 27,131,421 26,273,652

The accompanying notes are an integral part of these consolidated financial statements.

-1-

ESG INC.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

(Unaudited)

For the three months ended For the nine months ended
September 30, 2024 September 30, 2023 September 30, 2024 September 30, 2023
Revenues 2,234,549 518,192 7,122,611 5,959,055
Cost of goods sold 1,725,979 101,859 6,272,487 4,496,465
Gross Profit 508,570 416,333 850,123 1,462,590
Research and development cost 144,582 152,839 404,366 457,306
Selling expenses 2,292 1,263 4,776 1,863
General and administrative expense 239,656 279,953 703,078 876,271
Operating Income 122,041 (17,722 ) (262,096 ) 127,150
Interest (expense) (125,380 ) 62,553 (406,985 ) (287,134 )
Other Income (loss) (180 ) 29,652 (15,605 ) 133,180
Income (loss) before Income Taxes (3,521 ) 74,483 (684,686 ) (26,804 )
Income taxes - - - -
Consolidated net Income (loss) (3,521 ) 74,483 (684,686 ) (26,804 )
Less: Net income (loss) attributable to noncontrolling interest (26,218 ) 28,829 (201,063 ) 13,337
Net Income (Loss) Attributable to Shareholders of ESG Inc. 22,697 45,654 (483,623 ) (40,141 )
Other comprehensive items
Foreign currency translation gain (loss) attributable to ESG Inc. 161,997 (191,087 ) (5,616 ) (562,011 )
Foreign currency translation gain (loss) attributable to noncontrolling interest 55,390 (65,336 ) (1,920 ) (192,165 )
Total comprehensive income (loss) attributable to noncontrolling interest 29,173 (36,507 ) (202,983 ) (602,152 )
Total comprehensive Income (loss) Attributable to Shareholders of ESG Inc. 184,693 (145,433 ) (489,239 ) (178,828 )
Net income loss per share - basic and diluted 0.01 (0.01 ) (0.02 ) (0.01 )
Weighted average shares outstanding - basic and diluted 25,899,468 25,899,468 25,899,468 25,899,468

The accompanying notes are an integral part of these consolidated financial statements.

-2-

ESG INC.

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

(Unaudited)

Common stock Additional
paid aid-in
Accumulated
income
Accumulated
other
comprehensive
Total Company's Noncontrolling
Share Amount capital (deficit) Income equity interest Total
Balance at December 31, 2023 25,899,468 $ 25,900 $ 11,152,388 $ (1,224,811 ) $ (430,206 ) $ 9,523,271 $ 3,274,308 $ 12,797,579
Net loss - - - (587,667 ) - (587,667 ) (197,821 ) (785,488 )
Foreign currency translation adjustment - - - - (159,580 ) (159,580 ) (54,564 ) (214,144 )
Balance at March 31, 2024 25,899,468 25,900 11,152,388 (1,812,478 ) (589,786 ) 8,776,024 3,021,923 11,797,947
Net income - - - 81,347 - 81,347 22,976 104,323
Foreign currency translation adjustment - - - - (8,033 ) (8,033 ) (2,746 ) (10,779 )
Balance at June 30, 2024 25,899,468 25,900 11,152,388 (1,731,131 ) (597,819 ) 8,849,338 3,042,153 11,891,491
Net income (loss) - - - 22,697 - 22,697 (26,218 ) (3,521 )
Foreign currency translation adjustment - - - - 161,997 161,997 55,390 217,387
Balance at September 30, 2024 25,899,468 $ 25,900 $ 11,152,388 $ (1,708,434 ) $ (435,822 ) $ 9,034,032 $ 3,071,325 $ 12,105,357
Balance at December 31, 2022 25,899,468 25,900 11,152,388 (900,098 ) (148,590 ) 10,129,600 3,438,129 13,567,729
Net loss - - - (142,348 ) - (142,348 ) (40,100 ) (182,448 )
Foreign currency translation adjustment - - - - 43,059 43,059 14,723 57,782
Balance at March 31, 2023 25,899,468 25,900 11,152,388 (1,042,446 ) (105,531 ) 10,030,311 3,412,752 13,443,063
Net income - - - 56,553 - 56,553 24,608 81,161
Foreign currency translation adjustment - - - - (413,983 ) (413,983 ) (141,551 ) (555,534 )
Balance at June 30, 2023 25,899,468 25,900 11,152,388 (985,893 ) (519,514 ) 9,672,881 3,295,809 12,968,690
Net income - - - 45,654 - 45,654 28,829 74,483
Foreign currency translation adjustment - - - - (191,087 ) (191,087 ) (65,336 ) (256,423 )
Balance at September 30, 2023 25,899,468 $ 25,900 $ 11,152,388 $ (940,239 ) $ (710,601 ) $ 9,527,448 $ 3,259,302 $ 12,786,750

The accompanying notes are an integral part of these consolidated financial statements.

-3-

ESG INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

For The Nine Months Ended
September 30, 2024 September 30, 2023
Cash flows from operating activities:
Net loss $ (684,686 ) $ (26,804 )
Adjustments to reconcile loss to net cash used in operating activities:
Depreciation and amortization 1,362,759 1,092,743
Loss on obsolete inventories 201,480 -
Changes in assets and liabilities:
Accounts receivable and other receivable (131,305 ) (140,022 )
Advance to suppliers (1,042,212 ) (618,092 )
Inventory (218,401 ) 459,850
Value added tax receivable (168,859 ) -
Note receivable 41,848 17,010
Accounts payable 1,281,062 274,887
Payable to related party (30,000 ) 8,689
Accrued expenses and other payables 436,811 (33,776 )
Deferred income (97,493 ) (59,569 )
Net cash provided by operating activities 951,005 974,916
Cash flows from investing activities:
Acquisition of fixed assets (385,337 ) -
Net cash used in investing activities (385,337 ) -
Cash flows from financing activities:
Proceeds from loans 427,460 -
Payment of debt (470,206 ) (710,969 )
Net cash used in financing activities (42,746 ) (710,969 )
Effect of exchange rate changes on cash (420,429 ) (305,480 )
Net increase (decrease) in cash 102,493 (41,533 )
Cash, beginning of the period 342,342 206,621
Cash, end of the period $ 444,835 $ 165,088
Supplemental disclosures of cash flow information:
Cash paid for interest $ 406,985 $ 287,134
Cash paid for income tax $ - $ -

The accompanying notes are an integral part of these consolidated financial statements.

-4-

ESG INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2024

(Unaudited)

NOTE 1- ORGANIZATION AND DESCRIPTION OF BUSINESS

ESG Inc. ("ESG") was incorporated in July 2021 as a Nevada corporation and headquartered at Kennett Square, PA, USA. ESG is a holding company without operations and is engaged in food production and distribution through its subsidiaries.

ESG incorporated ESG China Limited as ESG's wholly owned subsidiary in Hong Kong on November 18, 2022. ESG China Limited incorporated Hainan ESG Technology Co., Ltd., a China corporation ("Hainan ESG") with 100% of ownership on January 16, 2023. ESG, ESG China Limited, and Hainan ESG have no operations.

On September 28, 2023, ESG entered into a share exchange agreement with Funan Allied United Farmer Products Co., Ltd., a China corporation incorporated in May 2017 ("AUFP"), and 74.52% of shareholders of AUFP, (each a "Shareholder," and collectively, the "Shareholders"), through Hainan ESG. Pursuant to such agreement, the Shareholders exchanged their equity of AUFP to Hainan ESG for shares of common stock of ESG, and ESG has agreed to offer 10,432,800 of ESG shares. Following this transaction, AUFP became a 74.52% subsidiary of ESG through Hainan ESG.

AUFP incorporated Anhui Allied United Mushroom Technology Co., Ltd. ("AUMT") in China in March 2018 to manufacture white button mushroom compost while AUFP incorporated Anhui Allied United Mushroom Co., Ltd. ("AUM") in China in April 2018 to grow fresh white button mushrooms and provide mushroom growing management services. AUFP, AUMT, and AUM are operating entities in China.

Prior to the share exchange, Mr. Zhi Yang owned 30%of AUFP, Fuyang Zhihan Agricultural Information Co. Ltd. ("Zhihan") owned 24.52% of AUFP and Mr. Chris Alonzo owned 10% of AUFP. ESG, after the share exchange agreement described above is completed, owns 74.52% of AUFP and its subsidiaries, AUM and AUMT in China. Currently Mr. Zhi Yang and Zhihan control 83.526% of ESG through DCG China Limited , and Mr. Christopher Alonzo owns 5.406% of ESG.

Since the Company is effectively controlled by the same controlling shareholders before and after the share exchange agreement, it is considered under common control. Therefore the above mentioned transactions were accounted for as a recapitalization. The reorganization has been accounted for at historical cost and prepared on the basis as if the aforementioned transactions had become effective as of the beginning of the first period presented in the accompanying financial statements of the Company.

Our operating subsidiaries are involved in direct white button mushroom composting, growing, food production, distribution, as well as import and export of Phase III compost and food to strategize. With the core business philosophy to develop and operate sustainable and technology-driven food businesses consistent with the principles of Environmental, Sustainable, and Governance investing, we believe that the growing global demand for sustainable high quality food presents a unique opportunity to operate companies engaged in this critical area that is being paid increasing attention by global investors.

-5-

NOTE 2- SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of presentation and consolidation

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") and include all adjustments necessary for the fair presentation of the Company's financial position for the periods presented.

The consolidated financial statements of the Company include the financial statements of the Company and its 74.52% owned subsidiaries in China. All inter-company transactions and balances between the Company and its subsidiaries have been eliminated upon consolidation. The Equity attributable to minority shareholders who own 25.48% of AUFP and its subsidiaries are non-controlling interest ("NCI"). The NCI were $3,071,325 and $3,274,308 as of September 30, 2024 and December 31, 2023, respectively.

Interim Financial Information

The unaudited financial statements have been prepared in accordance with generally accepted accounting principles (GAAP) applicable to interim financial information and the requirements of Form 10-Q and Rule 8-03 of Regulation S-X of the Securities and Exchange Commission. Accordingly, they do not include all of the information and disclosure required by accounting principles generally accepted in the United States of America for complete financial statements. Interim results are not necessarily indicative of results for a full year. In the opinion of management, all adjustments considered necessary for a fair presentation of the financial position and the results of operations and cash flows for the interim periods have been included. These financial statements should be read in conjunction with the audited financial statements as of and for the year ended December 31, 2023, as not all disclosures required by generally accepted accounting principles for annual financial statements are presented. The interim financial statements follow the same accounting policies and methods of computations as the audited financial statements as of and for the year ended December 31, 2023.

Use of estimates

In preparing the consolidated financial statements in conformity with U.S. GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities at the dates of consolidated financial statements, as well as the reported amounts of revenues and expenses during the reporting year. Significant items subject to such estimates and assumptions include allowance for doubtful accounts, advances to suppliers, valuation of inventories, useful lives of property, plant, and equipment, and intangible assets.

Cash and cash equivalent

Cash and cash equivalent includes demand deposits with financial institutions that are highly liquid in nature.

Account receivable

Accounts receivable are presented net of an allowance for doubtful accounts. The Company maintains an allowance for doubtful accounts for estimated losses. The Company reviews its accounts receivable on a periodic basis and makes general and specific allowance when there is doubt as to the collectability of individual balances. In evaluating the collectability of individual receivable balances, the Company considers many factors, including the age of the balance, customer's payment history, its current creditworthiness, and current economic trends. Accounts are written off after efforts at collection prove unsuccessful. As of September 30, 2024 and December 31, 2023, allowance for doubtful accounts was nil and nil , respectively.

Advances to suppliers, net

Advances to suppliers represent prepayments made to ensure continuous high-quality supplies and favorable purchase prices for premium quality. These advances are settled upon suppliers delivering raw materials to the Company when the transfer of ownership occurs. The Company review its advances to suppliers on a periodic basis and makes general and specific allowances when there is doubt as to the ability of a supplier to provide supplies to the Company or refund an advance. As of September 30, 2024 and December 31, 2023, advance to suppliers was $1,208,222 and $166,010, respectively and allowance for doubtful accounts was nil and nil, respectively.

-6-

Inventory

Inventory is comprised primarily of raw materials, work-in-progress and finished goods. The value of inventory is determined using the weighted average method. The Company periodically estimates an inventory allowance for estimated unmarketable inventories when necessary. Inventory amounts are reported in net of allowances.

Property, plant and equipment, net

Property, plant and equipment are stated at cost, less accumulated depreciation. Major repair and improvements that significantly extend original useful lives or improve productivity are capitalized and depreciated over the period benefited. Repair and maintenance costs are expensed as incurred. Depreciation is recorded principally by the straight-line method over the estimated useful lives of our property, plant and equipment which generally have the following ranges: buildings and improvements: 20 years; machinery and equipment: 5-10 years; office equipment: 3-5 years. Construction in progress is not depreciated until ready for service.

Intangible assets, net

Intangible assets with finite lives are amortized using the straight-line method over their estimated period of benefit. Evaluation of the recoverability of intangible assets is made to take into account events or circumstances that warrant revise estimates of useful lives or that indicate that impairment exists. All of the Company's intangible assets are subject to amortization. No impairment of intangible assets has been identified as of the balance sheet date.

Intangible assets consist of land use rights, patent and purchased software. Intangible assets are stated at cost less accumulated amortization. The land purchased for industrial use has the right of use for 50 years. We amortized the right to use land in 50 years. Patent and software amortized using the straight-line method with estimated useful lives of 12 years and 5 years, respectively.

Revenue recognition

The Company follows Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (ASC 606).

FASB ASC Topic 606 requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies each performance obligation.

Revenue is generated by selling fresh mushrooms to authorized distributors and wholesalers mainly in Yangzi River Delta. Contracts were signed after the communication of the price and quantities with customers. Our sales terms generally do not allow to sell without a deposit being made and do not allow for a right of return. Usually, the deposit from the customer equals or more than the sales amount. Control of the mushrooms is transferred upon receipt or loaded in the truck of carriers at our warehouse, as determined by the specific terms of the contract. Upon transfer of control to the customer, which completes our performance obligation, revenue is recognized.

Customer concentration

For the Three Months Ended September 30, (Unaudited) For the Nine Months Ended September 30, (Unaudited)
2024 2023 2024 2023
Customer A 25 % 21 % 17 % 20 %
Customer B 37 % - 20 % -
Customer C 19 % - 20 % -
Customer D 16 % - 15 % -
Customer E - 43 % - 42 %

-7-

Deferred income

Government grants (sometimes referred to as subsidies, subventions, etc.) are as assistance by government in the form of transfers of resources to an entity in return for past or future compliance with certain conditions relating to the operating activities of the entity. Deferred income consists primarily of government grants related to depreciable assets. Government grants received relating to depreciable assets are recorded as deferred income and recognized in over the life of the related assets. Company records income when receiving a grant which constitutes compensation for expenses or losses already incurred or for the purpose of giving immediate financial support to the entity with no future related costs. As of September 30, 2024 and December 31, 2023, deferred income was $1,271,088and $1,355,552, respectively.

Research and development expenses

Research and development expenses are expensed in the period when incurred. These costs primarily consist of cost of materials used, salaries paid for the Company's development department, and fees paid to the third parties. The research and development expenses were $144,582 and $152,839for the three months ended September 30, 2024 and 2023, respectively. The research and development expenses were $404,366 and $457,306for the nine months ended September 30, 2024 and 2023, respectively.

Noncontrolling interests

The Company follows FASB ASC Topic 810, "Consolidation," governing the accounting for and reporting of noncontrolling interests ("NCIs") in partially owned consolidated subsidiaries and the loss of control of subsidiaries. Certain provisions of this standard indicate, among other things, that NCI (previously referred to as minority interests) be treated as a separate component of equity, not as a liability, that increases and decreases in the parent's ownership interest that leave control intact be treated as equity transactions rather than as step acquisitions or dilution gains or losses, and that losses of a partially-owned consolidated subsidiary be allocated to non-controlling interests even when such allocation might result in a deficit balance.

The net income (loss) attributed to NCI was separately designated in the accompanying statements of operations and comprehensive income (loss). Losses attributable to NCI in a subsidiary may exceed a non-controlling interest's interests in the subsidiary's equity. The excess attributable to NCIs is attributed to those interests. NCIs shall continue to be attributed their share of losses even if that attribution results in a deficit NCI balance.

AUFP and its subsidiaries, AUM and AUMT were 25.48% owned by noncontrolling interest and $3,071,325 and $3,274,308 of equity were attributable to noncontrolling interest as of September 30, 2024 and December 31, 2023, respectively. During the three months ended September 30, 2024 and 2023, the Company had net loss of $26,218 and net income of $28,829, respectively, attributable to the noncontrolling interest. The Company had net loss of $201,063 and net income of $13,337, respectively, attributable to the noncontrolling interest for the nine months ended September 30, 2024 and 2023.

Foreign currency translation and comprehensive income (loss)

The accounts of the Company's Chinese entities are maintained in Chinese Yuan ("RMB") and the accounts of the U.S. parent company are maintained in United States dollar ("USD"). The accounts of the Chinese entities were translated into USD in accordance with FASB ASC Topic 830 "Foreign Currency Matters." All assets and liabilities were translated at the exchange rate on the balance sheet date; stockholders' equity is translated at historical rates and the statements of operations and cash flows are translated at the weighted average exchange rate for the period. The resulting translation adjustments are reported under other comprehensive income (loss) in accordance with FASB ASC Topic 220, "Comprehensive Income." Gains and losses resulting from foreign currency transactions are reflected in the statements of operations.

The Company follows FASB ASC Topic 220-10, "Comprehensive Income (loss)." Comprehensive income (loss) comprises net income (loss) and all changes to the statements of changes in stockholders' equity, except those due to investments by stockholders, changes in additional paid-in capital and distributions to stockholders.

The exchange rates used to translate amounts in RMB to USD for the purposes of preparing the CFS were as follows:

September 30, 2024 September 30, 2023 December 31, 2023
Period-end date USD: RMB exchange rate 7.0182 7.2952 7.0797
Average USD for the reporting period: RMB exchange rate 7.1773 7.0327 7.0750

-8-

Income taxes

The Company uses the asset and liability method of accounting for income taxes in accordance with FASB ASC Topic 740, "Income Taxes." Under this method, income tax expense is recognized for the amount of: (i) tax payable or refundable for the current period and (ii) deferred tax consequences of temporary differences resulting from matters that have been recognized in an entity's financial statements or tax returns. Deferred tax assets also include the prior year's net operating losses carried forward.


The Company accounts for income for income taxes in accordance with ASC 740, Income Taxes. ASC 740 requires an asset and liability approach for financial accounting and reporting for income taxes and allows recognition and measurement of deferred tax assets based upon the likelihood of realization of tax benefits in future years. Under the asset and liability approach, deferred taxes are provided for the net effects of temporary difference between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. A valuation allowance is provided for deferred tax assets if it is more likely than not these items will either expire before the Company is able to realize their benefits, or not be deductible in the future.

Contingencies

Certain conditions may exist as of the date the consolidated financial statements ("CFS") are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. In accordance with ASC 450, the Company's management and legal counsel assess such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company's legal counsel evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, the estimated liability would be accrued in the Company's CFS.

If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material, would be disclosed.

NOTE 3- GOING CONCERN

The accompanying consolidated financial statements were prepared assuming the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business. At September 30, 2024, the Company had negative working capital of $9,957,879. The Company had an accumulated deficit of approximately $1,708,434 and $1,224,811 as of September 30, 2024 and December 31, 2023, respectively. For nine month ended September 30, 2024, the Company had losses of $684,686and $26,804, respectively. These factors among others raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period of time.

To enhance our ability to continue to operate, we are dedicating resources to generate recurring revenues and sustainable operating cash flows. Currently, we are increasing our production capacity to generate more revenues and decrease unit cost.

NOTE 4- ACCOUNT RECEIVABLE AND OTHER RECEIVABLES

Account receivable and other receivable consisted of the following:

September 30,

2024

(Unaudited)

December 31,

2023

Accounts receivable $ 106,267 $ -
Other receivable 104,259 79,221
Total $ 210,526 $ 79,221

-9-

NOTE 5- PROPERTY, PLANT AND EQUIPMENT

The following table summarizes our property, plant and equipment:

September 30,

2024

(Unaudited)

December 31,

2023

Buildings and improvements $ 16,459,599 $ 16,276,614
Machinery, equipment and vehicle fleet 9,079,406 8,597,430
Construction in progress 21,926 21,682
Property, plant and equipment - cost 25,560,931 24,895,726
Less: Accumulated depreciation (7,612,223 ) (6,200,757 )
Property, plant and equipment - net $ 17,948,708 $ 18,694,969

For the three months ended September 30, 2024 and 2023, depreciation expenses were $444,538 and $364,247, respectively. For the nine months ended September 30, 2024 and 2023, depreciation expenses were $1,312,054 and $1,040,765, respectively.

NOTE 6- INVENTORIES

Inventories consisted of the following:

September 30,
2024 December 31,
(Unaudited) 2023
Raw materials $ 1,733,520 $ 1,516,634
Finished goods - -
Work in progress - compost 91,342 90,326
- growing mushrooms 44,915 44,416
Total $ 1,869,777 $ 1,651,376

NOTE 7- INTANGIBLE ASSETS

Intangible assets are stated at cost or acquisition-date fair value less accumulated amortization and consist of the following:

September 30,
2024

(Unaudited)

December 31,
2023
Land use right $ 3,365,401 $ 3,327,987
Software 7,787 7,701
Patent 7,124 7,045
Subtotal 3,380,313 3,342,733
Less: Accumulated amortization (311,799 ) (256,827 )
Total $ 3,068,514 $ 3,085,906

Amortization expenses were $18,288 and $17,594, respectively for the three months ended September 30, 2024 and 2023, respectively, $50,705 and $51,978for the nine months ended September 30, 2024 and 2023, respectively.

-10-

Estimated future amortization expense is as follows as of September 30, 2024:

Years ending December 31, Amortization expense
2024 73,151
2025 73,151
2026 73,151
2027 73,151
2028 73,151
Thereafter 2,702,759
Total 3,068,514

NOTE 8- BANK LOANS

Short-term bank loans consisted of the following:

September 30, 2024

(unaudited)

Interest

rate

Due date

December 31,

2023

Interest

rate

Due date
Agricultural Bank of China Funan Branch $ 812,174.06 4.50 % 4/06/25 $ 845,416 3.70 % 4/10/24
Anhui Funan Rural Commercial Bank 1,994,813 5.60 % 12/22/24 1,972,637 5.90 % 12/22/24
Anhui Funan Rural Commercial Bank 854,920 5.60 % 3/28/25 1,409,026 5.90 % 3/28/24
Anhui Funan Rural Commercial Bank 1,424,867 5.60 % 1/25/25 845,416 5.90 % 1/25/24
Industrial and Commercial Bank of China, Funan (1) 712,433 3.45 % 10/12/24 704,513 3.45 % 10/12/24
Bank of China Funan Branch (2) 1,139,893 3.60 % 3/13/25 1,127,220 3.60 % 3/13/25
Total $ 6,939,101 - - $ 6,904,228 - -

(1) $712,433 and $704,513 of loans from Industrial and Commercial Bank of China, Funan were pledged by fixed assets as of September 30, 2024 and December 31, 2023, respectively.

(2) $1,139,893 and $1,127,220 of loans from Bank of China were pledged by fixed assets as of September 30, 2024 and December 31, 2023, respectively.

NOTE 9- ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities consisted of the following:

September 30, 2024 December 31,
(Unaudited) 2023
Advances from customers $ 120,674 $ 63,867
Salary payable 105,099 181,950
Tax payable 13,951 16,131
Other payable 2,509,859 2,050,824
Total $ 2,749,583 $ 2,312,772

Other payable was primarily comprised of loans from non-bank institutions and deposit from customers. Loans included $284,973 and $281,805from Funan Agricultural Investment Co. Ltd as of September 30, 2024 and December 31, 2023, respectively and $1,424,867 and $1,409,026from Funan Small Business financing service center as of September 30, 2024 and December 31, 2023, respectively.

-11-

NOTE 10- VALUE ADDED TAX RECEIVABLE

Selling merchandise in China is generally subject to the value-added tax ("VAT"). The Company and its subsidiaries' primary operations are classified as agriculture products and its revenue is exempt from VAT and income tax. The amount of VAT liability is determined by applying the applicable tax rate to the invoiced amount of goods sold (output VAT) less VAT paid on purchases made with the relevant supporting invoices (input VAT). VAT input was primarily due to purchase of property, plant and equipment. As of September 30, 2024 and December 31, 2023, VAT input was $2,380,839 and $2,211,980, respectively. VAT input can deduct VAT output or be refunded when selling non-exempt goods. Anhui Allied United Mushroom Technology and Anhui Allied United Mushroom are engaged in agricultural production in China, and their value-added tax are exempted. The Company plans to produce processed mushrooms in the near future to utilize VAT input to offset VAT output.

NOTE 11- ASSET ACQUISITION

On May 11, 2021, Anhui Allied United Mushroom Co., Ltd. signed the Agreement ("Agreement") with Suhua Yang and Hao Yan, the owners of Funan Zhihua Mushroom Co., Ltd. ("Target Company"). As the consideration of transferring 100% equity of Target Company, AUM would pay Shareholders with $2,151,383 (RMB 14,840,028), which is $25,612 (RMB176,667) per month for 84 months at the end of each month after the delivery of the growing rooms. Target Company was dissolved after the asset acquisition.

NOTE 12- COMMITMENTS AND CONTINGENCIES

Commitments

On January 5, 2022, Funan Modern Recycling Agriculture Investment Co., Ltd. ("FMRA") signed an agreement with AUFP to fund AUFP 115 million RMB ($18.09 million) on the expansion of composting facilities including 6 bunkers and 22 tunnels. According to the agreement, AUFP transfers the land use right of 46,662 square meters which the composting facilities will be constructed on to FMRA and starts to pay rent for 10 years after AUFP uses the facilities. Once rents are paid, FMRA transfers the land use right and deed of composting facilities to AUFP. All the costs related to the transfer of land use right are paid by FMRA.

Legal contingencies

Management has identified certain legal mattes where we believe an unfavorable outcome is resonably estimated. Management believes that the total liabilities of the Company that may arise as a result of currently pending proceedings will not have a material adverse effect on the Company taken as a whole.

On September 3, 2021, Anhui Daquan Construction Company ("Daquan") filed a lawsuit against Funan Zhihua Mushroom Co., Ltd. (a merged company, "Zhihua") on unpaid contractual price of $48,744. Zhihua has a dispute on construction quality which did not meet the requirements specified in the contract and filed a lawsuit for $26,095 of damage. On June 6, 2023, Daquan paid $26,095 to Zhihua to settle the lawsuit.

On November 10, 2022, Funan Yuanlangju Construction Co., Ltd. filed a lawsuit against AUFP for $60,147. The plaintiff sold construction materials to AUFP. AUFP had a dispute with the plaintiff over the amount of the sale. On July 7, 2023, the two parties reached a settlement that AUFP paid the plaintiff $50,740 in 2023.

On December 2, 2022, Liu Pengpeng filed a lawsuit against AUFP for $66,066. Liu Pengpeng signed a contract with AUFP on installation work and drainage construction. Liu Pengpeng breached the contract and failed to complete the construction work on time which caused a loss to AUFP. On July 7, 2023, Liu Pengpeng withdrew the lawsuit. On November 20, 2023, Liu Pengpeng filed a lawsuit for the same claim. The lawsuit was settled in September, 2024.

NOTE 13- OTHER INCOME (LOSS)

Other income (loss) consists of incomes from government grants and losses from obsolete inventory write-offs:

For the three months ended
September 30, (Unaudited)
For the nine months ended
September 30, (Unaudited)
2024 2023 2024 2023
Asset-based grant $ 29,084 29,652 $ 97,493 133,180
Income-based grant - - 88,382 -
Total income from government grants 29,084 29,652 185,875 133,180
Loss on obsolete inventory write off (29,264 ) - (201,480 ) -
Other income (loss) $ (180 ) 29,652 $ (15,605 ) 133,180

-12-

NOTE 14- INCOME TAXES

The Company recorded no income taxes for the three and nine months ended September 30, 2024 and 2023. Net income and net loss were not offset among the operating subsidiaries. Net income of $584,785 and $563,375 were exempt from income tax for the three months ended September 2024 and 2023, respectively. Net income of $1,131,025and $1,647,017were exempt from income tax for the nine months ended September 30, 2024 and 2023, respectively.

The following table reconciles the U.S. statutory rates to the Company's effective tax rate for the three and nine months ended September 30, 2024 and 2023:

For the three months ended

September 30,

2024

September 30,
2023
(Unaudited) (Unaudited)
US federal statutory rates -21 % -21 %
Tax rate difference between PRC and U.S. -4 % -4 %
Effect of income tax exemption on certain income -141 % -170 %
Change in valuation allowance 166 % 195 %
Effective tax rate $ - $ -
For the nine months ended

September 30,

2024

September 30,

2023

(Unaudited) (Unaudited)
US federal statutory rates (21 %) (21 %)
Tax rate difference between PRC and U.S. (4 %) (4 %)
Effect of income tax exemption on certain income (29 %) (1206 %)
Change in valuation allowance 54 % 1231 %
Effective tax rate $ - $ -

The provision for income tax expense (benefit) for the nine months ended September 30, 2024 and 2023 consisted of the following:

For the nine months ended
September 30, 2024 September 30, 2023
(Unaudited) (Unaudited)
Income tax expense - current $ - $ -
Income tax benefit -deferred (374,704 ) (371,072 )
Increase in valuation allowance 374,704 371,072
Total income tax expense $ - $ -

September, 30, 2024

(Unaudited)

December 31, 2023
Deferred tax asset
Net operating loss $ (2,905,848 ) $ (2,531,144 )
Less: valuation allowance 2,905,848 2,531,144
Net deferred tax asset $ - $ -

-13-

NOTE 15- RELATED PARTY TRANSACTION

On October 22, 2022, Mr. Zhi Yang, the Company founder and CEO subscribed 12 million shares of common stock. Mr. Yang paid $30,000 for the 12,000,000 shares of ESG Inc. stock. The subscription was canceled on September 28, 2023, and the capital received were payable to Mr. Yang. The payable was paid off on February 5, 2024.

NOTE 16- EQUITY

The Company authorized 65,000,000 shares of common stock at par value of $0.001and 10,000,000 shares of preferred stock at par value $0.001. 25,899,468 shares of common stock were issued and outstanding as of September 30, 2024 and December 31, 2023. There were no preferred stock were issued as of September 30, 2024 and December 31, 2023.

NOTE 17- SUBSEQUENT EVENTS

The Company has evaluated subsequent events through the filing of this Quarterly Report on Form 10-Q, and determined that there have been no events that have occurred that would require adjustments to our disclosures in the consolidated financial statements

-14-

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

OPERATIONS REVIEW

Net Operating Revenues

Three Months Ended September 30, 2024 versus Three Months Ended September 30, 2023

During the three months ended September 30, 2024, net operating revenues were $122,041, compared to net loss of $17,722 during the three months ended September 30, 2023, an increase of $139,763 or 789%.

Nine Months Ended September 30, 2024 versus nine Months Ended September 30, 2023

During the nine months ended September 30 2024, net operating loss was $262,096, compared to $127,150 of net operating income during the nine months ended September 30, 2023, a decrease of $389,246, or 306%.

The decrease was due to the testing of expanded facility. After the expansion of triple capacity is completed, the Company started testing the expanded facility. From late July the expansion operates at 3 times of the capacity in 2023. We passed the testing phase this quarter and We expect the revenue and gross profit margin will increase in the fourth quarter.

Gross Profit Margin

Gross profit margin is a ratio calculated by dividing gross profit by net operating revenues. Our gross profit margin increased to 22.76% for the three months ended September 30, 2024, compared to 80.34% for the three months ended September 30, 2023. Our gross profit margin decreased to 11.94% for the nine months ended September 30, 2024, compared to 24.54% for the nine months ended September 30, 2023. The decrease was primarily due to the testing phase of expansion facility. We expect commodity costs to have a favorable impact on our gross profit margin during the fourth quart of 2024 after the expansion operation testing phases out and reaches its full capacity.

Research and Development Expenses

During the three months ended September 30, 2024, Research and development expenses decreased $8,257, or 5.40%, compared to $416,333 for the three months ended September 30, 2023. During the nine months ended September 30, 2024, Research and development expenses decreased $52,940, or 11.58%, compared to $457,306 for the nine months ended September 30, 2023. The difference was mainly due to the increase of currency exchange rate used to translate financial statements.

Selling, General Administrative Expenses

During the three months ended September, 2024, selling expenses increased $1,029, or 81.45%, compared to $1,263 for the three months ended September 30, 2023. During the three months ended September 30, 2024, general and administrative expenses decreased $40,297, or 14.39%, compared to $279,953 for the three months ended September 30, 2023. During the nine months ended September 30, 2024, selling expenses increased $2,913, or 156%, compared to $1,863, general and administrative expenses decreased $173,193, or 19.77%, compared to $876,271 for the nine months ended September 30, 2023. The decrease was mainly due to the decrease of professional fee and the fluctuation of foreign currency exchange rate.

Interest Expense

During the three months ended September 30, 2024, interest expense was decreased $187,933 or 300%, compared to negative $62,533 during the three months ended September 30, 2023. Negative $62,533 of interest expense was due to the interest forgiveness by the loaner during the three months ended September 30, 2023. During the nine months ended September 30, 2024, interest expenses were decreased $119,851, or 41.74%, compared to $287,134 during the nine months ended September 30, 2023. The decrease was primarily due to the impact of the reduce of loans and interest forgiveness.

-15-

Other income (loss)

During the three months ended September 30, 2024, other loss was $180, compared to $29,652 of net income during the three months ended September 30, 2023, a decrease of $29,832, or 101%. During the nine months ended September 30, 2024, other loss was $15,605, compared to $133,180 of net income during the nine months ended September 30, 2023. The decrease was mainly due to $29,246 and $201,480 of raw material write-off during the three and nine months ended September 30, 2024, respectively.

Income Taxes

The Company recorded no income taxes during the three and nine months ended September 30, 2024 and 2023, respectively.

LIQUIDITY, CAPITAL RESOURCES AND FINANCIAL POSITION

Cash Flows from Operating Activities

Net cash provided by operating activities during the nine months ended September 30, 2024 and 2023 was $951,005 and $974,916, respectively, a decrease of $23,911, or 2.45%. This decrease was primarily due to the decrease of revenue.

Cash Flows from Investing Activities

Net cash used in investing activities during the nine months ended September 30, 2024 and 2023 was $385,337 and $0, respectively. The increase was due to the purchase of production machine.

Cash Flows from Financing Activities

Net cash used in financing activities during the nine months ended September 30, 2024 and 2023 was $42,746 and $710,969, respectively. The Company made debt payment of $470,206 and borrowed $427,460 during the nine months ended September 30, 2024. The Company paid off $710,969 of debt during the nine months ended September 30, 2023.

Off-Balance Sheet Arrangements

There were no off-balance sheet arrangements as of September 30, 2024 and 2023, or that in the opinion of management that are likely to have, a current or future material effect on our financial condition or results of operations.

Contractual Obligations

None.

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

As a "smaller reporting company" as defined by Item 10 of Regulation S-K, the Company is not required to provide information required by this Item.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures

In connection with the preparation of this quarterly report, an evaluation was carried out by the Company's management, with the participation of the principal executive officer, of the effectiveness of the Company's disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act ("Exchange Act") as of September 30, 2024. Disclosure controls and procedures are designed to ensure that information required to be disclosed in reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the Commission's rules and forms, and that such information is accumulated and communicated to management, including the principal executive officer, to allow timely decisions regarding required disclosures.

Based on that evaluation, the Company's management concluded, as of the end of the period covered by this report, that the Company's disclosure controls and procedures were not effective in recording, processing, summarizing, and reporting information required to be disclosed, within the time periods specified in the Commission's rules and forms, and that such information was not accumulated and communicated to management, including the principal executive officer and the principal financial officer, to allow timely decisions regarding required disclosures.

Change in Internal Control over Financial Reporting

During the three months ended September 30, 2024, there have been no changes in internal control over financial reporting that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

-16-

PART II. Other Information

Item 1. Legal Proceedings

Management has identified certain legal matters where we believe an unfavorable outcome is reasonably estimated. Management believes that the total liabilities of the Company that may arise as a result of currently pending proceedings will not have a material adverse effect on the Company, taken as a whole.

On September 3, 2021, Anhui Daquan Construction Company ("Daquan") filed a lawsuit against Funan Zhihua Mushroom Co., Ltd. (a merged company, "Zhihua") on unpaid contractual price of $48,744. Zhihua has a dispute on construction quality which did not meet the requirements specified in the contract and filed a lawsuit for $26,095 of damages. On June 6, 2023, Daquan paid $26,095 to Zhihua to settle the lawsuit.

On November 10, 2022, Funan Yuanlangju Construction Co., Ltd. filed a lawsuit against AUFP for $60,147. The plaintiff sold construction materials to AUFP. AUFP had a dispute with the plaintiff over the amount of the sale. On July 7, 2023, the two parties reached a settlement that AUFP paid the plaintiff $50,740 in 2023.

On December 2, 2022, Liu Pengpeng filed a lawsuit against AUFP for $66,066. Liu Pengpeng signed a contract with AUFP on installation work and drainage construction. Liu Pengpeng breached the contract and failed to complete the construction work on time which caused a loss to AUFP. On July 7, 2023, Liu Pengpeng withdrew the lawsuit. On November 20, 2023, Liu Pengpeng filed a lawsuit for the same claim. The lawsuit was settled in September, 2024.

Item 1A. Risk Factors

As a "smaller reporting company" as defined by Item 10 of Regulation S-K, the Company is not required to provide information required by this Item.

Item 2. Unregistered Sale of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable to our Company.

Item 5. Other Information

None.

Item 6. Exhibits

The following exhibits are included as part of this report by reference:

31.1 Certification of Principal Executive Officer and Principal Financial Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(a) or 15d-14(a).
32.1 Certification of Principal Executive Officer and Principal Financial Officer pursuant to Securities Exchange Act of 1934 Rule 13a-14(b) or 15d-14(b) and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002.

-17-

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

ESG INC.
Date: November 13, 2024 By: /s/ Zhi Yang
Name: Zhi Yang
Title: President and CEO
(Principal Executive, Financial and Accounting Officer)

-18-